Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 1, 1996
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus
J K Powrie, G F Watts, M A Crook, et al.
Diabetes Care
|
December 29, 2000
Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects
D R Meeking, D L Browne, S Allard, et al.
Clinical Chemistry
|
August 1, 1986
Assessment of immunochemical methods for determining low concentrations of albumin in urine
G F Watts, J E Bennett, D J Rowe, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 25, 2005
The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes
F Wotherspoon, D L Browne, D R Meeking, et al.
Journal of Clinical Pathology
|
January 29, 2005
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
A S T Bickerton, N Clark, D Meeking, et al.
Lancet (London, England)
|
October 15, 1977
Deprenyl in Parkinson's disease
A J Lees, K M Shaw, L J Kohout, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 24, 2004
Reduced forearm reactive hyperaemia in normoalbuminuric subjects with Type 1 diabetes and retinopathy
J Gibney, B Turner, U Weis, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 5, 1999
Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria
D R Meeking, M H Cummings, S Thorne, et al.
International Journal of Clinical Practice
|
February 6, 2008
The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria
F Wotherspoon, D W Laight, C Turner, et al.
Psychopharmacology
|
April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'
J D Elsworth, V Glover, G P Reynolds, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 1, 1996
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus
J K Powrie, G F Watts, M A Crook, et al.
Diabetes Care
|
December 29, 2000
Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects
D R Meeking, D L Browne, S Allard, et al.
Clinical Chemistry
|
August 1, 1986
Assessment of immunochemical methods for determining low concentrations of albumin in urine
G F Watts, J E Bennett, D J Rowe, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 25, 2005
The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes
F Wotherspoon, D L Browne, D R Meeking, et al.
Journal of Clinical Pathology
|
January 29, 2005
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
A S T Bickerton, N Clark, D Meeking, et al.
Lancet (London, England)
|
October 15, 1977
Deprenyl in Parkinson's disease
A J Lees, K M Shaw, L J Kohout, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 24, 2004
Reduced forearm reactive hyperaemia in normoalbuminuric subjects with Type 1 diabetes and retinopathy
J Gibney, B Turner, U Weis, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 5, 1999
Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria
D R Meeking, M H Cummings, S Thorne, et al.
International Journal of Clinical Practice
|
February 6, 2008
The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria
F Wotherspoon, D W Laight, C Turner, et al.
Psychopharmacology
|
April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'
J D Elsworth, V Glover, G P Reynolds, et al.
Page
of 10